Tilray Brands (TLRY) Current Assets (2017 - 2026)
Tilray Brands' (TLRY) quarterly Current Assets came in at $792.1 million in Q2 2026, up 849.69% YoY from $83.4 million in Q2 2025, and up 10.21% on a QoQ basis from $718.8 million in Q1 2026.
Tilray Brands (TLRY) Current Assets (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Current Assets data on file, last reported at $792.1 million in Q2 2026.
- Quarterly Current Assets rose 849.69% year-over-year to $792.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $792.1 million (up 849.69% YoY) and the FY2026 annual result came in at $792.1 million, up 849.69% from the prior year.
- Current Assets advanced to $792.1 million in Q2 2026, from $718.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $910.9 million in Q3 2022 to a low of $67.4 million in Q1 2025.
- A 5-year average of $670.1 million and a median of $722.3 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2025 — Current Assets tumbled 89.33% — and 2026, when it soared 967.11%.
- Tracing TLRY's Current Assets over 5 years: stood at $814.7 million in 2022, then retreated by 21.2% to $642.0 million in 2023, then advanced by 10.17% to $707.3 million in 2024, then grew by 3.11% to $729.3 million in 2025, then rose by 8.61% to $792.1 million in 2026.
- The last three Current Assets figures came in at $792.1 million (Q2 2026), $718.8 million (Q1 2026), and $729.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Tilray Brands | 512.61 Mn | 277.98 Mn | 90.52 Mn | 792.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 792.13 Mn |
| Feb 28, 2026 | 718.76 Mn |
| Nov 30, 2025 | 729.32 Mn |
| Aug 31, 2025 | 701.14 Mn |
| May 31, 2025 | 83.41 Mn |
| Feb 28, 2025 | 67.36 Mn |
| Nov 30, 2024 | 707.34 Mn |
| Aug 31, 2024 | 725.88 Mn |
| May 31, 2024 | 677.71 Mn |
| Feb 29, 2024 | 631.21 Mn |
| Nov 30, 2023 | 642.03 Mn |
| Aug 31, 2023 | 829.26 Mn |
| May 31, 2023 | 773.03 Mn |
| Feb 28, 2023 | 758.51 Mn |
| Nov 30, 2022 | 814.71 Mn |
| Aug 31, 2022 | 910.88 Mn |
| May 31, 2022 | 803.50 Mn |
| Feb 28, 2022 | 695.79 Mn |
| Nov 30, 2021 | 708.28 Mn |
| Aug 31, 2021 | 844.62 Mn |